More Arovella Therapeutics Limited news
Arovella Therapeutics LimitedASX: ALA

Update

Mar 30, 2016 at 5:36 AM EDT · Issued by Arovella Therapeutics Limited

Filed with ASX · Mar 30, 2016 at 5:36 AM EDT

On 6ix: 6ix.com/news/update-92

View Attachment

6ix hasn’t read this filing yet.

Arovella Therapeutics Limited on 6ix

Earlier from Arovella Therapeutics

  • Response to ASX Price Query LetterMar 30, 2016
  • Priority Entitlement Issue ProspectusMar 30, 2016
  • Manufacturing updateMar 30, 2016
  • Eastland UpdateMar 30, 2016
  • Clinical Trial Update May 2011Mar 30, 2016

Later from Arovella Therapeutics

  • ArTiMist - CLINICAL TRIAL STATUS REPORTMar 30, 2016
  • Positive trial resultsMar 30, 2016
  • Appendix 3BMar 30, 2016
  • Financial Update and Refund Of Rights IssueMar 30, 2016
  • Eastland ArTiMist UpdateMar 30, 2016
All Arovella Therapeutics news releases↗

Follow Arovella Therapeutics into a list and get an email when it puts out news.

Follow Arovella Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer